ArticleClinicoEconomics and outcomes research : CEOR2018

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals.

Purificación Martínez Del Prado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.